CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi
Intest Res. 2018;16(2):233-245.   Published online April 30, 2018
DOI: https://doi.org/10.5217/ir.2018.16.2.233

Excel Download

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
Intestinal Research. 2018;16(2):233   Crossref logo
Link1 Link2 Link3

Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
Intestinal Research. 2018;16(3):499   Crossref logo
Link1 Link2 Link3

OC.06.1: Onset of Efficacy of Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in two Multinational, Phase 3 Clinical Trials
Digestive and Liver Disease. 2017;49:e90-e91   Crossref logo
Link1 Link2

P479 Analysis of haematological changes in tofacitinib-treated patients with ulcerative colitis across Phase 3 induction and maintenance studies
Journal of Crohn's and Colitis. 2019;13(Supplement_1):S351-S352   Crossref logo
Link1

Mo1781 Tofacitinib Plasma Concentration Monitoring Is Not Needed for Optimization of Induction Therapy in Moderate to Severe Ulcerative Colitis: Results of Pooled Exposure-Response Analyses of Phase 3 Induction Studies
Gastroenterology. 2016;150(4):S774   Crossref logo
Link1 Link2

P531 Efficacy of tofacitinib maintenance therapy for ulcerative colitis in remitting patients vs. patients with clinical response after 8 weeks of induction treatment
Journal of Crohn's and Colitis. 2019;13(Supplement_1):S378-S379   Crossref logo
Link1

Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Inflammatory Intestinal Diseases. 2019;4(4):131-143   Crossref logo
Link1 Link2

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
Alimentary Pharmacology & Therapeutics. 2012;37(2):204-213   Crossref logo
Link1

Tu1752 – Analysis of Hematological Changes in Tofacitinib-Treated Patients with Ulcerative Colitis Across Phase 3 Induction and Maintenance Studies
Gastroenterology. 2019;156(6):S-1111   Crossref logo
Link1 Link2

Tu2003 Improvement in Patient-Reported Outcomes in Two Phase 3 Induction Studies of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis
Gastroenterology. 2016;150(4):S1003   Crossref logo
Link1 Link2